Taiwan’s PharmaEngine signs Asia deal with VC-backed Nanobiotix
Taiwanese biopharmaceutical company PharmaEngine has agreed to form a strategic partnership with VC-backed Nanobiotix, to hasten the development of one of the French nanomedicine firm’s products.
The product in question is known as NBTXR3 and forms part of Nanobiotix's NanoXray pipeline. In forming an alliance with Nanobiotix, PharmaEngine will conduct further clinical studies on the product, leveraging...
More on Healthcare
Latest News
AVCJ Awards 2022: Exit of the Year – IPO: GoTo
GoTo’s rocky start on the Indonesia Stock Exchange betrays the pioneering nature of the listing and cements a legacy as an ecosystem lynchpin. Long-time backer Openspace Ventures reflects
New Zealand hydrogen player raises $14m
New Zealand hydrogen and zero-emission technologies developer Fabrum has raised a NZD 23m (USD 14.5m) Series A round led by UK-based AP Ventures.
Japan's Baseconnect gets $41m Series B
Japanese corporate contact and recruitment database provider Baseconnect has raised a JPY 5.4bn (USD 41m) Series B round led by Z Venture Capital (ZVC), formerly YJ Capital.
Carlyle launches tender offer for Japan's Iwasaki Electric
Iwasaki Electric, a Japanese lighting solutions provider that has worked on projects ranging from sports stadiums to hospitals, is set to be acquired by The Carlyle Group through a tender offer at a valuation of JPY 34.9bn (USD 266m).